Internal fiducial markers and susceptibility effects in MRI - Simulation and measurement of spatial accuracy

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 5, 2012, Pages 1612-1618

  Jonsson, Joakim H ^a   Garpebring, Anders ^a   Karlsson, Magnus G ^a   Nyholm, Tufve ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Fiducial markers; Gold; Magnetic resonance; Radiotherapy; Susceptibility

Indexed keywords

COMPUTED TOMOGRAPHY; DIFFERENT SHAPES; FIDUCIAL MARKER; FIELD PERTURBATIONS; INTERNAL STRUCTURE; MAGNETIC FIELD DISTORTION; MAIN MAGNETIC FIELDS; PHANTOM MEASUREMENTS; PLANNING CT; PROSTATE CANCERS; SIMULATION SOFTWARE; SIMULATIONS AND MEASUREMENTS; SPATIAL ACCURACY; TARGET DELINEATION; TARGET VOLUMES; TREATMENT PLANNING;

COMPUTER SOFTWARE; GOLD; MAGNETIC FIELDS; MAGNETIC RESONANCE; MAGNETIC RESONANCE IMAGING; MAGNETIC SUSCEPTIBILITY; RADIOTHERAPY;

COMPUTERIZED TOMOGRAPHY;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; FIDUCIAL MARKER; IMAGE QUALITY; IMAGE RECONSTRUCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIMULATION; VALIDATION STUDY; X RAY;

ARTIFACTS; FIDUCIAL MARKERS; GOLD; HUMANS; MAGNETIC FIELDS; MAGNETIC RESONANCE IMAGING; MALE; MOVEMENT; PATIENT POSITIONING; PHANTOMS, IMAGING; PROSTATE; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, IMAGE-GUIDED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84858704868     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.01.046     Document Type: Article

References (16)

1. Njeh CF. Tumor delineation: The weakest link in the search for accuracy in radiotherapy. J Med Phys 2008;33:136-140.
2. Gao Z, Wilkins D, Eapen L, et al. A study of prostate delineation referenced against a gold standard created from the visible human data. Radiother Oncol 2007;85:239-246. (Pubitemid 350160996)
3. Rasch C, Barillot I, Remeijer P, et al. Definition of the prostate in CTand MRI: A multi-observer study. Int J Radiat Oncol Biol Phys 1999;43:57-66. (Pubitemid 29065832)
4. Villeirs GM, Van Vaerenbergh K, Vakaet L, et al. Interobserver delineation variation using CT versus combined CT + MRI in intensity-modulated radiotherapy for prostate cancer. Strahlenther Onkol 2005;181:424-430. (Pubitemid 40956578)
5. Debois M, Oyen R, Maes F, et al. The contribution of magnetic resonance imaging to the three-dimensional treatment planning of localized prostate cancer. Int J Radiat Oncol Biol Phys 1999; 45:857-865. (Pubitemid 29525447)
6. Parker CC, Damyanovich A, Haycocks T, et al. Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration. Radiother Oncol 2003;66: 217-224. (Pubitemid 36315832)
7. Khoo VS, Padhani AR, Tanner SF, et al. Comparison of MRI with CT for the radiotherapy planning of prostate cancer: A feasibility study. Br J Radiol 1999;72:590-597. (Pubitemid 29295033)
8. Chen L, Price RA Jr., Nguyen TB, et al. Dosimetric evaluation of MRI-based treatment planning for prostate cancer. Phys Med Biol 2004;49:5157-5170. (Pubitemid 39585550)
9. Chen L, Price RA Jr.,Wang L, et al. MRI-based treatment planning for radiotherapy: Dosimetric verification for prostate IMRT. Int J Radiat Oncol Biol Phys 2004;60:636-647. (Pubitemid 39233486)
10. Lee YK, Bollet M, Charles-Edwards G, et al. Radiotherapy treatment planning of prostate cancer using magnetic resonance imaging alone. Radiother Oncol 2003;66:203-216. (Pubitemid 36315831)
11. Nyholm T, Nyberg M, Karlsson MG, et al. Systematisation of spatial uncertainties for comparison between a MR and a CT-based radiotherapy workflow for prostate treatments. Radiat Oncol 2009;4:54.
12. Pasquier D, Betrouni N, Vermandel M, et al.MRI alone simulation for conformal radiation therapy of prostate cancer: Technical aspects. Conf Proc IEEE Eng Med Biol Soc 2006;1:160-163. (Pubitemid 46519822)
13. Prabhakar R, Julka PK, Ganesh T, et al. Feasibility of using MRI alone for 3D radiation treatment planning in brain tumors. Jpn J Clin Oncol 2007;37:405-411. (Pubitemid 47249475)
14. Schenck JF. The role of magnetic susceptibility in magnetic resonance imaging: MRI magnetic compatibility of the first and second kinds. Med Phys 1996;23:815-850. (Pubitemid 26192503)
15. de Rochefort L, Nguyen T, Brown R, et al. In vivo quantification of contrast agent concentration using the induced magnetic field for time-resolved arterial input function measurement with MRI. Med Phys 2008;35:5328-5339.
16. Silvestri Z, Davis RS, Geneves G, et al. Volume magnetic susceptibility of gold-platinum alloys: Possible materials to make mass standards for the watt balance experiment. Metrologia 2003;40:172-176.